Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2019-12-02 2019-12-02
Drug Identification Number 02279614 02279614
Brand name APO-TOPIRAMATE APO-TOPIRAMATE
Common or Proper name TOPIRAMATE TOPIRAMATE
Company Name APOTEX INC APOTEX INC
Ingredients TOPIRAMATE TOPIRAMATE
Strength(s) 25MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-07 2019-10-07
Estimated end date 2019-11-29 2019-11-29
Actual end date 2019-11-29 2019-11-29
Shortage status Resolved Resolved
Company comments
Health Canada comments